Discrepancies Between Prescribed and Actual Pediatric Home Parenteral Nutrition Solutions. (18th April 2016)

• Record Type: Journal Article
• Authors: Raphael, Bram P.; Murphy, Margaret; Gura, Kathleen M.; Litman, Heather; Dalton, Meghan K.; Finkelstein, Jonathan A.; Lightdale, Jenifer R.
• Is Part Of: Nutrition in clinical practice. Volume 31:Number 5(2016:Oct.)
• Page Start: 654
• Page End: 658
• Publication Date: 2016-04-18
• Subjects: parenteral nutrition -- home total parenteral nutrition -- parenteral nutrition solutions -- compounding -- medication errors; Nutrition -- Periodicals; Diet therapy -- Periodicals; Artificial feeding -- Periodicals; 615.854
• DOI: 10.1177/0884533616639410
• Languages: English
• ISSNs: 0884-5336

Abstract

Abstract : Background: Home parenteral nutrition (HPN) is increasingly prescribed for pediatric patients with complex medical conditions. Commercial vendors are widely available to compound HPN. The aim of this study was to determine the frequency of discrepancies between written HPN prescriptions and commercially compounded solutions, as well as to record the associated severity of harm from discrepancies. Methods: From January to April 2013, 2 clinical pharmacists independently and prospectively reconciled HPN compounding records with electronic prescriptions (gold standard) during all routine ambulatory encounters to a multidisciplinary HPN program. Types, severity, and causes of discrepancies were recorded. Results: Sixty‐one unique patients were identified for inclusion during 117 visits. HPN solutions were compounded at 13 unique vendors across 14 states. Of all 100 compounding records, 46 (46%) contained at least 1 discrepancy, with a total of 60 discrepancies identified, affecting 34 of 61 (56%) patients. There was at least 1 discrepancy in solutions originating from 10 of 13 (77%) home infusion companies. Discrepancies were classified as Medication Error Reporting and Prevention levels C (n = 37) and D (n = 23; ie, all reaching patient but not causing harm). Conclusions: We found an alarmingly high rate of preparation discrepancies in a cohort of pediatric patients receiving HPN. Routine reconciliation of HPN compounds with intended prescriptions may be critical for ambulatory patients receiving this high‐risk therapy. While home infusion commercial vendors provide an indispensable function, discrepancies and errors with potential for harm may be more common than previously appreciated.